Chemotherapy choice in advanced pancreatic cancer: What patient and disease factors influence prescription patterns?

Authors

null

William Raskin

Queen's University, Kingston, ON, Canada

William Raskin , Helen Guo , Jaclyn Marie Beca , Wanrudee Isaranuwatchai , Lucy Qiao , Craig Earle , Scott R. Berry , James Joseph Biagi , Stephen Welch , Brandon Matthew Meyers , Nicole Mittmann , Natalie G. Coburn , Aliya Pardhan , Jessica Arias , Deborah Schwartz , Scott Gavura , Leta Marie Forbes , Robin McLeod , Erin Diane Kennedy , Kelvin K. Chan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Translational Research

Citation

J Clin Oncol 36, 2018 (suppl 4S; abstr 327)

DOI

10.1200/JCO.2018.36.4_suppl.327

Abstract #

327

Poster Bd #

F12

Abstract Disclosures

Similar Posters

First Author: Moonho Kim

Poster

2023 ASCO Gastrointestinal Cancers Symposium

First-line chemotherapy regimens associated with survival in advanced pancreatic cancer: A Mexican single-center, real-world study.

First-line chemotherapy regimens associated with survival in advanced pancreatic cancer: A Mexican single-center, real-world study.

First Author: Marytere Herrera

First Author: Matthew Anaka